TODD STRATEGY GROUP

Lobbying for KALEO · Pharmaceutical company.

Filing 2nd Quarter - Termination

2nd Quarter (Apr 1 - June 30) 2026 · Virginia · $40,000.00 income · posted Jul 12, 2026

Lobbying activity 1

Pharmacy

Prescription drug pricing. Medical countermeasure development and procurement.

Source: federal Lobbying Disclosure Act filing. Bills are parsed from the activity descriptions.

Report a problem